230 related articles for article (PubMed ID: 24980821)
1. Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma.
Zhu LM; Shi DM; Dai Q; Cheng XJ; Yao WY; Sun PH; Ding Y; Qiao MM; Wu YL; Jiang SH; Tu SP
Oncotarget; 2014 Jul; 5(14):5403-15. PubMed ID: 24980821
[TBL] [Abstract][Full Text] [Related]
2. [XAF1 inhibits cell proliferation and induces apoptosis in human lung adenocarcinoma cell line A549 in vitro].
Chen D; Zhang F; Sang Y; Zhu R; Zhang H; Chen Y
Zhongguo Fei Ai Za Zhi; 2014 Dec; 17(12):829-33. PubMed ID: 25539606
[TBL] [Abstract][Full Text] [Related]
3. Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin.
Ma B; Wang Y; Zhou X; Huang P; Zhang R; Liu T; Cui C; Liu X; Wang Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):419-29. PubMed ID: 25240826
[TBL] [Abstract][Full Text] [Related]
4. Experimental study on inhibition effects of the XAF1 gene against lung cancer cell proliferation.
Yang WT; Chen DL; Zhang FQ; Xia YC; Zhu RY; Zhou DS; Chen YB
Asian Pac J Cancer Prev; 2014; 15(18):7825-9. PubMed ID: 25292071
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus encoding XAF-1 and TNF‑α in the same open reading frame efficiently inhibits hepatocellular cancer cells.
Li K; Li X; Wu Z; Zheng L; Cui Y; Wang J; Huang Y; Yan Z
Mol Med Rep; 2016 Jun; 13(6):5169-76. PubMed ID: 27121136
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
Augello C; Caruso L; Maggioni M; Donadon M; Montorsi M; Santambrogio R; Torzilli G; Vaira V; Pellegrini C; Roncalli M; Coggi G; Bosari S
BMC Cancer; 2009 Apr; 9():125. PubMed ID: 19397802
[TBL] [Abstract][Full Text] [Related]
7. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
[TBL] [Abstract][Full Text] [Related]
8. XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer.
Huang J; Yao WY; Zhu Q; Tu SP; Yuan F; Wang HF; Zhang YP; Yuan YZ
Cancer Sci; 2010 Feb; 101(2):559-67. PubMed ID: 19922503
[TBL] [Abstract][Full Text] [Related]
9. Restoration of XAF1 expression induces apoptosis and inhibits tumor growth in gastric cancer.
Tu SP; Liston P; Cui JT; Lin MC; Jiang XH; Yang Y; Gu Q; Jiang SH; Lum CT; Kung HF; Korneluk RG; Wong BC
Int J Cancer; 2009 Aug; 125(3):688-97. PubMed ID: 19358264
[TBL] [Abstract][Full Text] [Related]
10. XAF1 as a prognostic biomarker and therapeutic target in squamous cell lung cancer.
Chen YB; Shu J; Yang WT; Shi L; Guo XF; Wang FG; Qian YY
Chin Med J (Engl); 2011 Oct; 124(20):3238-43. PubMed ID: 22088514
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression.
Tu SP; Sun YW; Cui JT; Zou B; Lin MC; Gu Q; Jiang SH; Kung HF; Korneluk RG; Wong BC
Cancer; 2010 Mar; 116(5):1252-63. PubMed ID: 20082449
[TBL] [Abstract][Full Text] [Related]
13. Role of X‑linked inhibitor of apoptosis‑associated factor‑1 in vasculogenic mimicry in ovarian cancer.
Wang Y; Liu P; Wang X; Mao H
Mol Med Rep; 2017 Jul; 16(1):325-330. PubMed ID: 28534973
[TBL] [Abstract][Full Text] [Related]
14. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
15. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P
Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793
[TBL] [Abstract][Full Text] [Related]
16. The XAF1 tumor suppressor induces autophagic cell death via upregulation of Beclin-1 and inhibition of Akt pathway.
Sun PH; Zhu LM; Qiao MM; Zhang YP; Jiang SH; Wu YL; Tu SP
Cancer Lett; 2011 Nov; 310(2):170-80. PubMed ID: 21788101
[TBL] [Abstract][Full Text] [Related]
17. P18 peptide, a functional fragment of pigment epithelial-derived factor, inhibits angiogenesis in hepatocellular carcinoma via modulating VEGF/VEGFR2 signalling pathway.
Wang X; Xiu P; Wang F; Zhong J; Wei H; Xu Z; Liu F; Li J
Oncol Rep; 2017 Aug; 38(2):755-766. PubMed ID: 28627623
[TBL] [Abstract][Full Text] [Related]
18. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
[TBL] [Abstract][Full Text] [Related]
19. Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
Arora V; Cheung HH; Plenchette S; Micali OC; Liston P; Korneluk RG
J Biol Chem; 2007 Sep; 282(36):26202-9. PubMed ID: 17613533
[TBL] [Abstract][Full Text] [Related]
20. Combined use of adenoviral vector Ad5/F35-mediated APE1 siRNA enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in hepatoma cells in vitro and in vivo.
Cun Y; Zhang Q; Xiong C; Li M; Dai N; Zhang S; Wang D
Oncol Rep; 2013 Jun; 29(6):2197-204. PubMed ID: 23563597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
